Cargando…
Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer
INTRODUCTION: Peroxiredoxin-1 (PRDX1) is a multifunctional protein, acting as a hydrogen peroxide (H(2)O(2)) scavenger, molecular chaperone and immune modulator. Although differential PRDX1 expression has been described in many tumors, the potential role of PRDX1 in breast cancer remains highly ambi...
Autores principales: | O’Leary, Patrick C, Terrile, Marta, Bajor, Malgorzata, Gaj, Pawel, Hennessy, Bryan T, Mills, Gordon B, Zagozdzon, Agnieszka, O’Connor, Darran P, Brennan, Donal J, Connor, Kate, Li, Jane, Gonzalez-Angulo, Ana Maria, Sun, Han-Dong, Pu, Jian-Xin, Pontén, Fredrik, Uhlén, Mathias, Jirström, Karin, Nowis, Dominika A, Crown, John P, Zagozdzon, Radoslaw, Gallagher, William M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226972/ https://www.ncbi.nlm.nih.gov/pubmed/25011585 http://dx.doi.org/10.1186/bcr3691 |
Ejemplares similares
-
Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents
por: Bajor, Malgorzata, et al.
Publicado: (2018) -
Generation of a new bioluminescent model for visualisation of mammary tumour development in transgenic mice
por: Zagozdzon, Agnieszka M, et al.
Publicado: (2012) -
Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma
por: Trzeciecka, Anna, et al.
Publicado: (2015) -
Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer
por: Brennan, Donal J, et al.
Publicado: (2010) -
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen
por: Brennan, Donal J, et al.
Publicado: (2011)